Scientists Explore What GLP-1 Drugs Could Mean for Long-Term Kidney Health
Summary
Scientists studied drugs called GLP-1 receptor agonists, used for diabetes and weight loss, and found they may help protect kidney health in people with bipolar disorder and chronic kidney disease. Their research showed those taking these drugs were less likely to need dialysis or a kidney transplant over five years.Key Facts
- GLP-1 receptor agonists include drugs like Ozempic and Wegovy.
- These drugs are commonly used to treat diabetes and manage weight.
- People with bipolar disorder have higher rates of chronic kidney disease.
- Long-term use of lithium, a bipolar disorder medicine, can harm kidney function.
- The study analyzed health data from 1.5 million adults with bipolar disorder; 96,000 had kidney disease.
- Among those with both conditions, those taking GLP-1 drugs had a 44% lower risk of needing dialysis or kidney transplant.
- The research highlights a potential new benefit of GLP-1 drugs for kidney health in this group.
- The study was published in the Journal of Affective Disorders.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
